Cybin Corp.

Compass Pathways Files for an IPO at NASDAQ UK-based Compass Pathways wants to become the first psychedelics company to list on a major U.S. stock exchange. The psilocybin research company intends to make its initial public offering (IPO) through NASDAQ under the ticker symbol...

Cybin Corp., a Canadian life sciences company focused on psychedelics and mushroom-psilocybin research, announced a new partnership with the Toronto Centre for Psychedelic Science. With this partnership, the centers' co-founders, Rotem Petranker and Thomas Anderson will be appointed exclusive...